Cardiff Oncology, Inc. (CRDF)
0.9073
-0.02
(-2.23%)
USD |
NASDAQ |
Oct 23, 16:00
0.9006
-0.01
(-0.74%)
After-Hours: 20:00
Cardiff Oncology Market Cap : 62.15M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 62.15M |
| October 22, 2026 | 63.57M |
| October 21, 2026 | 64.32M |
| October 20, 2026 | 63.81M |
| October 19, 2026 | 60.67M |
| October 16, 2026 | 61.73M |
| October 15, 2026 | 66.52M |
| October 14, 2026 | 66.68M |
| October 13, 2026 | 69.19M |
| October 12, 2026 | 71.24M |
| October 09, 2026 | 73.98M |
| October 08, 2026 | 72.61M |
| October 07, 2026 | 74.67M |
| October 06, 2026 | 73.30M |
| October 05, 2026 | 78.09M |
| October 02, 2026 | 76.72M |
| October 01, 2026 | 80.83M |
| September 30, 2026 | 82.89M |
| September 29, 2026 | 80.15M |
| September 28, 2026 | 82.20M |
| September 25, 2026 | 84.94M |
| September 24, 2026 | 87.68M |
| September 23, 2026 | 89.74M |
| September 22, 2026 | 91.11M |
| September 21, 2026 | 93.85M |
| Date | Value |
|---|---|
| September 18, 2026 | 93.85M |
| September 17, 2026 | 89.05M |
| September 16, 2026 | 92.48M |
| September 15, 2026 | 91.79M |
| September 14, 2026 | 89.74M |
| September 11, 2026 | 82.89M |
| September 10, 2026 | 82.89M |
| September 09, 2026 | 71.93M |
| September 08, 2026 | 75.35M |
| September 04, 2026 | 74.67M |
| September 03, 2026 | 73.98M |
| September 02, 2026 | 72.61M |
| September 01, 2026 | 70.56M |
| August 31, 2026 | 68.06M |
| August 28, 2026 | 64.39M |
| August 27, 2026 | 67.55M |
| August 26, 2026 | 67.41M |
| August 25, 2026 | 69.87M |
| August 24, 2026 | 68.36M |
| August 21, 2026 | 60.29M |
| August 20, 2026 | 62.25M |
| August 19, 2026 | 61.51M |
| August 18, 2026 | 60.70M |
| August 17, 2026 | 61.95M |
| August 14, 2026 | 65.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PS Ratio | 121.24 |
| Price to Book Value | 2.342 |
| Price | 0.9073 |
| Earnings Yield | -65.09% |